source
- Q32 Bio appoints José Trevejo as chief medical officer, coming from Enveda TherapeuticsSTAT+ ran its regular "up and down the ladder" column highlighting recent personnel moves in the pharma sector. The feature invites readers to share hiring, promotion and departure news for broader…
- Viking Therapeutics commercial chief exits after nine months; Gilead eyes BeOne executive for China growthViking Therapeutics' chief commercial officer Neil Aubuchon left the company after only nine months in the role, according to Peer Review. His brief tenure has sparked speculation about the compan…